Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain

Purpose Oral methylnaltrexone was shown to be effective in treating opioid-induced constipation (OIC) in patients with chronic noncancer pain in a Phase III randomized controlled trial. This report provides a detailed safety analysis from that study.